In this interactive presentation, the co-founder of biotechnology firm Regeneron shares the principles of innovation that he ...

SELLAS Life Sciences CEO Angelos Stergiou and "Some Future Day" author Marc Beckman predict artificial intelligence will ...

SMC proteins can reverse direction, reshaping DNA and solving key scientific debates. This discovery could impact research on ...

Sam Altman-backed Retro Biosciences is raising $1 billion to develop drugs that extend human lifespan by 10 years, the FT ...

The pseudoscientific practice of physiognomy, dismissed as junk science centuries ago, is seeing a high-tech revival.

Retro Biosciences will back clinical trials for three drugs—including a potential Alzheimer’s disease treatment set to begin ...